Pyxis Oncology, Inc. (PYXS) vs Zentalis Pharmaceuticals, Inc. (ZNTL)
Pyxis Oncology, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Pyxis Oncology, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($260.4M and $250.2M). Across the 8 metrics below, Zentalis Pharmaceuticals, Inc. leads on 5 and Pyxis Oncology, Inc. on 3.
Valuation
Profitability
| Metric | PYXS | ZNTL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (179.10%) | (66.75%) | (57.72%) |
| Return on assets | (99.62%) | (49.22%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack